Literature DB >> 6243918

Characterization of herpes simplex virus strains isolated from patients with various diseases.

S Dundarov, P Andonov, B Bakalov.   

Abstract

Herpes simplex virus strains (HSV) were isolated from various herpetic diseases. These HSV-strains isolated in Bulgaria (687) and in other countries (13) were studied by the neutralization test using standard type specific rabbit antisera and human gamma globulin. The serotype distribution of all strains showed: HSV-1 = 323 strains, HSV-2 = 372 strains, 5 strains behaved antigenically intermediate. A close correlation between the serotype of the strains and the localization of the lesions was established. All but four strains (1.24 per cent) isolated from the head belong to HSV-1, and only six HSV-strains (1.9 per cent) from lesions with other localizations were not HSV-2. Within six months to 8 years 2 to 4 herpes strains were isolated repeatedly from 30 patients. In 23 of these cases they were identical and in the other they showed different biological (3) or antigenical (4) properties. The results suggest, that under natural conditions some HSV-intermediate strains may exist.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6243918     DOI: 10.1007/bf01320768

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  15 in total

1.  Biochemical classification of herpes simplex virus types 1 and 2, and of intermediate strains on the basis of different susceptibilities of thymidine kinase to thymidine analogues.

Authors:  I Just; S Dundaroff; D Falke
Journal:  Acta Virol       Date:  1976-02       Impact factor: 1.162

2.  SEROLOGICAL COMPARISON OF THE HERPES VIRUSES.

Authors:  G PLUMMER
Journal:  Br J Exp Pathol       Date:  1964-04

3.  Studies on herpes simplex virus. I. An antigenic analysis of four strains of virus isolatec from a human subject.

Authors:  G A GARABEDIAN; J T SYVERTON
Journal:  J Infect Dis       Date:  1955 Jan-Feb       Impact factor: 5.226

4.  Induction capacity and influence of dThdMP on thymidine kinase activity of type 1 and 2 strains of herpes simplex virus.

Authors:  S Dundarov; D Dundarova; S Todorov; L Kavaklova; D Falke
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

5.  Late 19S rabbit antibody neutralization test for differentiating herpes simplex virus types 1 and 2.

Authors:  B Hampar; L M Martos; M Chakrabarty; M A Burroughs
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

Review 6.  Antigens of herpes simplex virus of oral and genital origin.

Authors:  P Wildy
Journal:  Cancer Res       Date:  1973-06       Impact factor: 12.701

7.  Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.

Authors:  P M Ejercito; E D Kieff; B Roizman
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

8.  [Herpes simplex virus type 1 and 2 in various disease enities].

Authors:  K E Schneweis
Journal:  Dtsch Med Wochenschr       Date:  1967-12-15       Impact factor: 0.628

9.  Association of antigenic type of Herpesvirus hominis with site of viral recovery.

Authors:  W R Dowdle; A J Nahmias; R W Harwell; F P Pauls
Journal:  J Immunol       Date:  1967-11       Impact factor: 5.422

10.  Influence of double infections on the induction of thymidine kinase by UV-irradiated herpes simplex virus types 1 and 2 and pseudorabies virus.

Authors:  S Dundaroff; I Just; D Falke
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

View more
  2 in total

1.  Cellular polypeptides overexpressed after herpes simplex infection permit virus subtyping and may help diagnose cervical cancer.

Authors:  J M Davis; N B La Thangue; D L Taylor; D S Latchman; M Anderson; A S Tyms
Journal:  Genitourin Med       Date:  1988-10

Review 2.  Recent advances in vaccine development for herpes simplex virus types I and II.

Authors:  Jeffrey L Coleman; Deepak Shukla
Journal:  Hum Vaccin Immunother       Date:  2013-02-26       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.